Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System

NCT06142461 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Change in landscape of HPV treatment

Conditions

Interventions

Sponsor

PharmaJet, Inc.

Collaborators